Skip navigation
Use este identificador para citar ou linkar para este item: http://repositorio.unb.br/handle/10482/48374
Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
ARTIGO_AnalysisEssentialMedicines.pdf864,54 kBAdobe PDFVisualizar/Abrir
Registro completo de metadados
Campo DCValorIdioma
dc.contributor.authorLuz, Tatiana Chama Borges-
dc.contributor.authorTavares, Noemia Urruth Leão-
dc.contributor.authorMarques, Isabela Cristina-
dc.contributor.authorCastro, Ana Karine Sarvel de-
dc.contributor.authorCota, Betania Barros-
dc.date.accessioned2024-06-24T12:55:47Z-
dc.date.available2024-06-24T12:55:47Z-
dc.date.issued2022-
dc.identifier.citationLUZ, Tatiana Chama Borges et al. An analysis of the essential medicines policy in primary care: findings from MedMinas project. Frontiers in Pharmacology, [S. l.], v. 13, out. 2022. DOI: https://doi.org/10.3389/fphar.2022.953329. Disponível em: https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.953329/full. Acesso em: 24 jun. 2024.pt_BR
dc.identifier.urihttp://repositorio2.unb.br/jspui/handle/10482/48374-
dc.language.isoengpt_BR
dc.publisherFrontierspt_BR
dc.rightsAcesso Abertopt_BR
dc.titleAn analysis of the essential medicines policy in primary care : findings from MedMinas projectpt_BR
dc.typeArtigopt_BR
dc.subject.keywordMedicamentos - política - Brasilpt_BR
dc.subject.keywordAtenção primária à saúdept_BR
dc.rights.license© 2022 Luz, Tavares, Marques, de Castro and Cota. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.pt_BR
dc.identifier.doihttps://doi.org/10.3389/fphar.2022.953329pt_BR
dc.description.abstract1Background: Essential Medicines Policy (EMP) has been adopted in Brazil to improve the provision and use of pharmaceuticals. This mixed methods study aims to bring evidence of the EMP implemented in municipalities in the context of primary care in Minas Gerais (20,997,560 inhabitants), Southeast Brazil. Methods: We analysed the core output of the EMP, i.e., the municipal essential medicines lists (MEML) and the effects of the policy on the procurement and availability of medicines. Data sources included a sample of 1,019 individuals (patients, health managers and health professionals), 995 prescriptions, 2,365 dispensed medicines and policy documents from 26 municipalities. Data were collected between April and October 2019. Document analysis and thematic content analysis were performed, and four availability indexes were estimated. Results: The findings suggest an overall lack of standardised and methodologically sound procedures to elaborate the MEML. Funding and public purchasing processes were found to be the major obstacles to medicine procurement. Only 63% of medicines were available at public community pharmacies and just 46.2% of patients had full access to their pharmaceutical treatment. Conclusion: This study reveals weaknesses in the implementation of EMP and a clear disconnection between medicines selection, procurement, and availability, the three core elements of the supply system. These findings contribute to informing future policy improvement actions to strengthen this system. Other countries aiming to advance towards universal health coverage may learn from the challenges that primary care in Brazil still needs to address.pt_BR
dc.contributor.affiliationOswaldo Cruz Foundation (FIOCRUZ), René Rachou Institute (IRR), GETESA (Grupo de Estudos Transdisciplinares em Tecnologias em Saúde e Ambiente)pt_BR
dc.contributor.affiliationStrathclyde University, Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS), Glasgow, United Kingdompt_BR
dc.contributor.affiliationFaculty of Health Sciences, University of Brasília, Department of Pharmacypt_BR
dc.contributor.affiliationOswaldo Cruz Foundation (FIOCRUZ), René Rachou Institute (IRR), GETESA (Grupo de Estudos Transdisciplinares em Tecnologias em Saúde e Ambiente)pt_BR
dc.contributor.affiliationOswaldo Cruz Foundation (FIOCRUZ), René Rachou Institute (IRR), GETESA (Grupo de Estudos Transdisciplinares em Tecnologias em Saúde e Ambiente)pt_BR
dc.contributor.affiliationOswaldo Cruz Foundation (FIOCRUZ), René Rachou Institute (IRR), GETESA (Grupo de Estudos Transdisciplinares em Tecnologias em Saúde e Ambiente)pt_BR
dc.description.unidadeFaculdade de Ciências da Saúde (FS)pt_BR
dc.description.unidadeDepartamento de Farmácia (FS FAR)pt_BR
Aparece nas coleções:Artigos publicados em periódicos e afins

Mostrar registro simples do item Visualizar estatísticas



Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.